newsfilter
← Latest News
GlobeNewswire·

Clearmind Announces Patent Publication in Japan Covering Treatment for Neurological Movement Disorder

Published patent application covers 3-MMC-based treatment of dyskinesia, including in combination with Palmitoylethanolamide (PEA) Vancouver, Canada, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc.